Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04339777
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT01593475
What this trial is testing

Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma

Who this might be right for
Pancreatic Carcinoma Non-resectable
National Cancer Center, Korea 44
Testing effectiveness (Phase 2)Study completedNCT02066675
What this trial is testing

Trabectedin First Line Therapy In Unfit Sarcoma Study

Who this might be right for
Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to ReceiveStandard Chemotherapy
Italian Sarcoma Group 24
Testing effectiveness (Phase 2)Looking for participantsNCT06690775
What this trial is testing

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+1 more
TORL Biotherapeutics, LLC 230
Testing effectiveness (Phase 2)Study completedNCT06528457
What this trial is testing

Study to Examine the Effects of Oral Fenretinide

Who this might be right for
Dengue
Island Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT04566601
What this trial is testing

Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

Who this might be right for
Borderline Personality Disorder
Boehringer Ingelheim 390
Testing effectiveness (Phase 2)UnknownNCT05134519
What this trial is testing

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00479167
What this trial is testing

A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Rush University Medical Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06488300
What this trial is testing

Assessing Antiviral Treatments in Early Symptomatic RSV

Who this might be right for
Respiratory Syncytial VirusRespiratory Syncytial Virus, Human
University of Oxford 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07223307
What this trial is testing

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Who this might be right for
Liver CancerIntrahepatic CholangiocarcinomaLiver Metastases+1 more
Stanford University 62
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Study completedNCT06920836
What this trial is testing

QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study

Who this might be right for
Cough
Wuhan Createrna Science and Technology Co., Ltd 270
Testing effectiveness (Phase 2)Ended earlyNCT01671111
What this trial is testing

Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell Transfusions
Shire 30
Testing effectiveness (Phase 2)Ended earlyNCT02551731
What this trial is testing

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

Who this might be right for
Spasms, Infantile
INSYS Therapeutics Inc 9
Testing effectiveness (Phase 2)Study completedNCT03697629
What this trial is testing

An Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Canadian Myeloma Research Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715931
What this trial is testing

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionHER2-positive Gastric Cancer
Yu jiren 30
Testing effectiveness (Phase 2)Study completedNCT00150072
What this trial is testing

Efficacy and Safety of Imatinib in Chordoma

Who this might be right for
Chordoma
Novartis Pharmaceuticals 55
Testing effectiveness (Phase 2)Study completedNCT02203695
What this trial is testing

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Testing effectiveness (Phase 2)Ended earlyNCT01523639
What this trial is testing

A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis

Who this might be right for
Colorectal CancerSteatohepatitis
Austrian Breast & Colorectal Cancer Study Group 8
Not applicableStudy completedNCT01937377
What this trial is testing

GLORIA-AF Registry Program (Phase II/III)

Who this might be right for
StrokeAtrial Fibrillation
Boehringer Ingelheim 200
Next Page